Mirati Therapeutics, Inc.

FMR LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

4,240

Value ($000)

249

Weight

0.0%

2013 Q4 - 2023 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	249	0.0%	4,240	12/31/2023
2023 Q3	11/13/2023	66,552	0.0%	1,527,828	9/30/2023
2023 Q2	8/11/2023	4,472	0.0%	123,783	6/30/2023
2023 Q1	5/11/2023	6,621	0.0%	178,083	3/31/2023
2022 Q4	2/13/2023	31,084	0.0%	686,028	12/31/2022
2022 Q3	11/10/2022	149,502	0.0%	2,140,622	9/30/2022
2022 Q2	8/12/2022	134,761	0.0%	2,007,464	6/30/2022
2022 Q1	5/13/2022	192,852	0.0%	2,345,577	3/31/2022
2021 Q4	2/14/2022	401,315	0.0%	2,735,803	12/31/2021
2021 Q3	2/14/2022	468,858	0.0%	2,650,261	9/30/2021
2021 Q2	8/13/2021	429,755	0.0%	2,660,526	6/30/2021
2021 Q1	5/14/2021	476,817	0.0%	2,783,524	3/31/2021
2020 Q4	2/8/2021	610,239	0.1%	2,778,358	12/31/2020
2020 Q3	11/13/2020	412,734	0.0%	2,485,602	9/30/2020
2020 Q2	8/24/2020	236,391	0.0%	2,070,525	6/30/2020
2020 Q1	5/14/2020	213,139	0.0%	2,772,713	3/31/2020
2019 Q4	2/7/2020	259,759	0.0%	2,015,821	12/31/2019
2014 Q1	5/15/2014	27,351	0.0%	1,434,261	3/31/2014
2013 Q4	2/13/2014	12,161	0.0%	731,275	12/31/2013